November 2012
Atossa Therapeutics was founded in 2009 and its headquarters is located in Seattle, Wash. The company joined the public market in November 2012 and ATOS stock trades on the Nasdaq Exchange.
How many shares of Atos are there?
Share Statistics
| Avg Vol (3 month) 3 | 21.39M |
|---|---|
| Shares Outstanding 5 | 120.82M |
| Implied Shares Outstanding 6 | N/A |
| Float | 120.8M |
| % Held by Insiders 1 | 0.04% |
What does Atossa Therapeutics sell?
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
What does Atossa Therapeutics Inc do?
Atossa Therapeutics Inc., formerly Atossa Genetics Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics and delivery methods for breast cancer and other breast conditions. Its pipeline includes two programs: endoxifen and intraductal microcatheter technology.
Is Atos stock a buy?
Maxim Group is very positive about ATOS and gave it a “Buy” rating on September 18, 2020. The price target was set to $8.00….Predicted Opening Price for Atossa Genetics Inc. of Thursday, August 12, 2021.
| Fair opening price August 12, 2021 | Current price |
|---|---|
| $3.19 | $3.18 (Undervalued) |
Is Atos a buy or sell?
Atossa Therapeutics has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Is Atossa a buy?
Why is Atos dropping today?
Shares of Atossa Therapeutics (NASDAQ:ATOS) were tumbling 22.8% as of 11:36 a.m. EDT on Wednesday. The decline came after the company announced final results from its phase 2 clinical study evaluating oral endoxifen in treating breast cancer with administration between diagnosis and surgery.
Is Atossa stock a buy?
Will Atossa Therapeutics stock go up?
Atossa Therapeutics Inc (NASDAQ:ATOS) The 2 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 7.50, with a high estimate of 8.00 and a low estimate of 7.00. The median estimate represents a +123.88% increase from the last price of 3.35.
What kind of company is Atossa Therapeutics Inc?
Atossa Therapeutics, Inc. (ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need, today announced a new drug development program called COVID-19 HOPE.
How many shares of common stock does Atossa have?
As part of the meeting, Atossa management has decided to withdraw from consideration the proposal to increase authorized shares of common stock by 325 million.
What are G & A expenses for Atossa Therapeutics?
G&A expenses consist primarily of personnel and related benefit costs, facilities, professional services, insurance, and public company related expenses.
What are general and administrative expenses for Atos?
General and Administrative ExpensesG&A expenses were $2,152,000 for the three months ended March 31, 2021, an increase of $154,000, or 8% from the total G&A expenses for the three months ended March 31, 2020, of $1,998,000.
